Literature DB >> 24114187

Functional imaging to predict tumor response in locally advanced cervical cancer.

Tara D Barwick1, Alexandra Taylor, Andrea Rockall.   

Abstract

Worldwide, cervical cancer is the third commonest cancer. Prognostic factors for cervical cancer include tumor size, histological subtype, histological grade, International Federation of Gynecology and Obstetrics (FIGO) stage, nodal status and performance status. However these known parameters are not sufficient to accurately predict treatment response or prognosis. There is a clinical need for noninvasive prognostic biomarkers to provide more detailed tumor characterization at the baseline and/or early during therapy, which may permit personalized treatment and potentially improve outcomes. Functional imaging techniques have been developing rapidly over the past decade. Imaging parameters derived from PET/CT and functional MRI techniques are emerging as promising response biomarkers. This review details the current evidence and future potential of functional imaging to predict tumor response in locally advanced cervical carcinoma.

Entities:  

Mesh:

Year:  2013        PMID: 24114187     DOI: 10.1007/s11912-013-0344-2

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  90 in total

1.  Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma.

Authors:  E A Boss; L F Massuger; L A Pop; L C Verhoef; H J Huisman; H Boonstra; J O Barentsz
Journal:  J Magn Reson Imaging       Date:  2001-04       Impact factor: 4.813

Review 2.  Biological predictors of cervical cancer response to radiation therapy.

Authors:  Ann H Klopp; Patricia J Eifel
Journal:  Semin Radiat Oncol       Date:  2012-04       Impact factor: 5.934

3.  FDG-PET-based prognostic nomograms for locally advanced cervical cancer.

Authors:  Elizabeth A Kidd; Issam El Naqa; Barry A Siegel; Farrokh Dehdashti; Perry W Grigsby
Journal:  Gynecol Oncol       Date:  2012-06-24       Impact factor: 5.482

4.  18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response.

Authors:  Charles Kunos; Tomas Radivoyevitch; Fadi W Abdul-Karim; Peter Faulhaber
Journal:  Int J Gynecol Cancer       Date:  2011-08       Impact factor: 3.437

5.  Posttherapy surveillance of women with cervical cancer: an outcomes analysis.

Authors:  D Bodurka-Bevers; M Morris; P J Eifel; C Levenback; M W Bevers; K R Lucas; J T Wharton
Journal:  Gynecol Oncol       Date:  2000-08       Impact factor: 5.482

Review 6.  Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis.

Authors:  Sugama Chicklore; Vicky Goh; Musib Siddique; Arunabha Roy; Paul K Marsden; Gary J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-13       Impact factor: 9.236

7.  Diffusion-weighted magnetic resonance imaging of uterine cervical cancer.

Authors:  Ying Liu; Renju Bai; Haoran Sun; Haidong Liu; Dehua Wang
Journal:  J Comput Assist Tomogr       Date:  2009 Nov-Dec       Impact factor: 1.826

8.  Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix.

Authors:  M Höckel; B Vorndran; K Schlenger; E Baussmann; P G Knapstein
Journal:  Gynecol Oncol       Date:  1993-11       Impact factor: 5.482

9.  Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients.

Authors:  Stavroula Kyriazi; David J Collins; Christina Messiou; Kjell Pennert; Robert L Davidson; Sharon L Giles; Stan B Kaye; Nandita M Desouza
Journal:  Radiology       Date:  2011-08-09       Impact factor: 11.105

10.  Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images.

Authors:  Kate Downey; Sophie F Riches; Veronica A Morgan; Sharon L Giles; Ayoma D Attygalle; Tom E Ind; Desmond P J Barton; John H Shepherd; Nandita M deSouza
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

View more
  11 in total

1.  Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.

Authors:  Lucia Manganaro; Yulia Lakhman; Nishat Bharwani; Benedetta Gui; Silvia Gigli; Valeria Vinci; Stefania Rizzo; Aki Kido; Teresa Margarida Cunha; Evis Sala; Andrea Rockall; Rosemarie Forstner; Stephanie Nougaret
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

2.  A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer.

Authors:  Antoine Schernberg; Sylvain Reuze; Fanny Orlhac; Irène Buvat; Laurent Dercle; Roger Sun; Elaine Limkin; Alexandre Escande; Christine Haie-Meder; Eric Deutsch; Cyrus Chargari; Charlotte Robert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-15       Impact factor: 9.236

Review 3.  Radiotherapy response evaluation using FDG PET-CT-established and emerging applications.

Authors:  Helen Cliffe; Chirag Patel; Robin Prestwich; Andrew Scarsbrook
Journal:  Br J Radiol       Date:  2017-01-30       Impact factor: 3.039

4.  Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.

Authors:  Si Gao; Siyao Du; Zaiming Lu; Jun Xin; Song Gao; Hongzan Sun
Journal:  Eur Radiol       Date:  2019-09-06       Impact factor: 5.315

5.  MRI-based radiomics for pretreatment prediction of response to concurrent chemoradiotherapy in locally advanced cervical squamous cell cancer.

Authors:  Xiaomiao Zhang; Qi Zhang; Xiaoduo Yu; Xinming Zhao; Yan Chen; Sicong Wang; Jieying Zhang; Jusheng An; Lizhi Xie
Journal:  Abdom Radiol (NY)       Date:  2022-10-12

Review 6.  What's New in Imaging for Gynecologic Cancer?

Authors:  Sairah R Khan; Mubarik Arshad; Kathryn Wallitt; Victoria Stewart; Nishat Bharwani; Tara D Barwick
Journal:  Curr Oncol Rep       Date:  2017-11-06       Impact factor: 5.075

7.  Assessment of Hypoxic Tissue Fraction and Prediction of Survival in Cervical Carcinoma by Dynamic Contrast-Enhanced MRI.

Authors:  Jon-Vidar Gaustad; Einar K Rofstad
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

Review 8.  A practical review of magnetic resonance imaging for the evaluation and management of cervical cancer.

Authors:  Emma C Fields; Elisabeth Weiss
Journal:  Radiat Oncol       Date:  2016-02-02       Impact factor: 3.481

9.  EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques.

Authors:  Katrien Vandecasteele; Philippe Tummers; Mieke Van Bockstal; Pieter De Visschere; Tom Vercauteren; Werner De Gersem; Hannelore Denys; Eline Naert; Amin Makar; Wilfried De Neve
Journal:  BMC Cancer       Date:  2018-09-17       Impact factor: 4.430

10.  DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.

Authors:  Kjersti V Lund; Trude G Simonsen; Gunnar B Kristensen; Einar K Rofstad
Journal:  Radiat Oncol       Date:  2020-04-15       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.